Measurement characteristics of two asthma symptom diary scales for use in clinical trials

European Respiratory Journal

Volumn 10, Issue 3, 1997, Pages 646-651

  Santanello, N C ^a   Barber, B L ^a   Reiss, T F ^a   Friedman, B S ^a   Juniper, E F ^b   Zhang, J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

asthma; outcomes research; questionnaires; reliability and validity

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; PLACEBO;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; QUESTIONNAIRE; SYMPTOM; TREATMENT OUTCOME;

ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY FUNCTION TESTS;

EID: 0031041207     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47(2): 76-83.
2. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147: 832-838.
3. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Long-term effects of budesonide on airway responsiveness and clinical asthma severity in inhaled steroid-dependent asthmatics. Eur Respir J 1990; 3: 1122-1127.
4. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyporesponsiveness and clinical asthma in nonsteroid;dependent asthmatics. Am Rev Respir Dis 1990; 142: 832-836.
5. Abramson MJ, Hensley MJ, Saunders NA, Wloclarczyk JH. Evaluation of a new asthma questionnaire. J Asthma 1991; 28(2): 129-139.
6. Malo JL, L'Archeveque J, Trudeau C, d'Aquino C, Cartier A. Should we monitor peak expiratory flow rates or record symptoms with a simple diary in the management of asthma? J Allergy Clin Immunol 1993; 91: 702-709.
7. Malo JL, Cartier A, Merland N, et al. Four-times-a-day dosing frequency is better than a twice-a-day regimen in subjects requiring a high-dose inhaled steroid budesonide, to control moderate to severe asthma. Am Rev Respir Dis 1989;140(3): 624-628.
8. 2-agonists on lung function, airway responsiveness and symptoms in children with asthma. Am Rev Respir Dis 1992; 146(3): 547-554.
9. Gibson PG, Wong BJ, Hepperle MJ, et al. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin Exp Allergy 1991; 22: 525-532.
10. Steen N, Hutchinson A, McColl E, et al. Development of a symptom based outcome measure for asthma. BMJ 1994; 309: 1065-1068.
11. O'Connor GT, Weiss ST. Clinical and symptom measures. Am J Respir Crit Care Med 1994; 149: S21-S28.
12. Cronbach LJ. Coefficient alpha and the internal structure of test. Psychometrika 1951; 16(3): 297-334.
13. Nunnally JC. In: Psychometric Theory. 2nd edn. New York, McGraw-Hill, 1978.
14. Mosteller F, Tukey JW. In: Data Analysis and Regression. Philippines, Addison-Wesley Publishing Co., Inc., 1977.
15. Deyo RA, Diehr P, Patrick D. Reproducibility and health status measures: statistics and strategies for evaluation. Control Clin Trials 1991; 12(4): 142S-158S.
16. Streiner DL, Norman GR. In: Health Measurement Scales: a Practical Guide to their Development and Use. Oxford University Press, 1989.
17. Tukey JW, Ciminera JL, Heyse JF. Testing the statistical certainty of a response to increasing doses of a drug. Biometrics 1985; 41: 295-301.
18. McFadden ER. Clinical physiologic correlates in asthma. J Allergy Clin Immunol 1986: 77: 1-5.
19. Higgs CM, Richardson RB, Lea DA, Lewis GT, Lazlo G. Influence of knowledge of peak flow on self-assessment of asthma: studies with a coded peak flow meter. Thorax. 1986; 41: 671-675.
20. Chapman K, Friedman BS, Shingo S, Heyse J, Reiss T, Spector R. The efficacy of an oral leukotriene synthesis inhibitor (MK-0591) in asthmatics treated with inhaled steroids. Am Rev Respir Dis 1994; 149A: 215.